HiberGene Receives CE Mark for Meningitis MDx | GenomeWeb

NEW YORK (GenomeWeb) – Dublin, Ireland-based HiberGene Diagnostics announced today the CE-IVD marking and launch of its first molecular assay, a test for bacterial meningitis.

Called HG Meningococcus, the test uses loop-mediated isothermal amplification to detect the DNA of all known pathogenic Neisseria meningitidis serogroups, and "meets a significant unmet clinical need using advanced and proven technology," HiberGene CEO Brendan Farrell said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.